Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10987275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory effect of full-length human endostatin on in vitro angiogenesis.

  1999cited by this paper
• Positive Interaction between 5-FU and FdUMP[10] in the Inhibition of Human Colorectal Tumor Cell Proliferation

  1999cited by this paper
• Fragment E derived from both fibrin and fibrinogen stimulates interleukin-6 production in rat peritoneal macrophages.

  1999cited by this paper
• Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.

  1999cited by this paper
• Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin*

  1998cited by this paper
• Endogenous angiogenesis inhibitors: angiostatin, endostatin, and other proteolytic fragments.

  1998cited by this paper
• Fibrinogen is a ligand for integrin alpha5beta1 on endothelial cells.

  1997cited by this paper
• Fibrinogen Is a Ligand for Integrin α5β1 on Endothelial Cells*

  1997cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Expression of adhesion molecules in cultured human pulmonary microvascular endothelial cells.

  1995cited by this paper
• Angiogenesis and Fibrin Degradation in Human Breast Cancer

  1994cited by this paper
• Cytokine networks in solid human tumors: regulation of angiogenesis

  1994cited by this paper
• Angiogenic activity of fibrin degradation products is located in fibrin fragment E

  1992cited by this paper
• Fibrinogen deposition without thrombin generation in primary human breast cancer tissue.

  1991cited by this paper
• Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.

  1989cited by this paper
• Coagulation-cancer interaction in situ in renal cell carcinoma.

  1986cited by this paper
• Immunologic Identification of the Cleavage Products from the Aα- and Bβ-Chains in the Early Stages of Plasmin Digestion of Fibrinogen

  1986cited by this paper
• Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.

  1985cited by this paper
• Stimulation of fibrinogen synthesis in cultured rat hepatocytes by fibrinogen fragment E.

  1985cited by this paper
• Fibrinogen and fibrin.

  1981cited by this paper

• The unseen architects of metastasis: coagulation factors in pre-metastatic niche development.

  2026cites this paper
• Fibrinolysis-unrelated functions of the plasminogen/plasmin system: A gateway to successful parasitism?

  2026cites this paper
• A new hemostatic agent composed of Zn2+-enriched Ca2+ alginate activates vascular endothelial cells in vitro and promotes tissue repair invivo

  2022cites this paper
• The Role of Fibrin(ogen) in Wound Healing and Infection Control

  2021cites this paper
• Customizable 3D-Printed (Co-)Cultivation Systems for In Vitro Study of Angiogenesis

  2020cites this paper
• Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical model

  2020cites this paper
• Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin–AKT Signaling Pathway in Lung Cancer

  2020cites this paper
• Alphastatin-Loaded Chitosan Nanoparticle Preparation and Its Antiangiogenic Effect on Lung Carcinoma

  2019cites this paper
• Polymer Design and Development

  2017cites this paper
• Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor–specific inhibitor

  2017cites this paper
• Peptides derived from plasma proteins released by bothropasin, a metalloprotease present in the Bothrops jararaca venom

  2017cites this paper
• A novel modified physiologically relevant model for cardiac angiogenesis.

  2017cites this paper
• Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis

  2015cites this paper
• The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease

  2015cites this paper
• Inflammation-mediating proteases: structure, function in (patho) physiology and inhibition.

  2014cites this paper
• A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice

  2013cites this paper
• Promotion of mammalian angiogenesis by plant-derived secondary metabolites

  2013cites this paper
• Myofibroblasts and the Vascular Endothelium : Impact of Fibrin Degradation Products and miRNA on Vascular Motility and Function

  2013cites this paper
• Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay.

  2013cites this paper
• Growth Regulation of Nervous System Tumours: Models for Assessment of Angiogenesis in Brain Tumours

  2012cites this paper
• Novel Aspects of Fibrin(ogen) Fragments during Inflammation

  2011cites this paper
• Analysis of the urinary peptidome associated with Helicobacter pylori infection.

  2011cites this paper
• A novel fragment derived from the β chain of human fibrinogen, β43–63, is a potent inhibitor of activated endothelial cells in vitro and in vivo

  2010influential citation
• Potential in vitro effects of carbon nanotubes on human aortic endothelial cells.

  2009cites this paper
• Role of Tissue Factor in Cancer

  2009cites this paper
• A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line.

  2009cites this paper
• Tissue Factor in Cancer Angiogenesis and Coagulopathy

  2007cites this paper
• Identification of key residues involved in mediating the in vivo anti‐tumor/anti‐endothelial activity of Alphastatin

  2007cites this paper
• A novel three-dimensional model to quantify metastatic melanoma invasion

  2007cites this paper
• High plasma D-dimer level is associated with decreased survival in patients with lung cancer.

  2007cites this paper
• Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) binds to fibrinogen fragments D and E, but not to native fibrinogen.

  2006cites this paper
• Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2)

  2006cites this paper
• Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma

  2006cites this paper
• Identification of differentially expressed proteins in human malignant pleural effusions

  2006cites this paper
• The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities.

  2006cites this paper
• Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property

  2006cites this paper
• The role of phosphoinositide 3-kinase/akt signaling pathway in tumor-associated angiogenesis, wound healing, and carcinogenesis.

  2006cites this paper
• Identification of differentially expressed proteins in human malignant pleural

  2006cites this paper
• Identification of differentially expressed proteins in human malignant pleural effusions

  2006cites this paper
• Identification of novel angiogenesis inhibitors.

  2005cites this paper
• Mechanisms of Angiogenesis

  2005cites this paper
• The hemostatic system in angiogenesis.

  2005cites this paper
• Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses.

  2005cites this paper
• Angiostatin.

  2005cites this paper
• Angiogenesis inhibitors found within the haemostasis pathway

  2005cites this paper
• Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo.

  2004cites this paper
• Contribution of the hemostatic system to angiogenesis in cancer.

  2004cites this paper
• Tissue Factor and Fibrin in Tumor Angiogenesis

  2004cites this paper
• On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via alphavbeta3 integrin.

  2004cites this paper
• Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.

  2004cites this paper
• On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via αvβ3 integrin

  2004cites this paper
• Effects of Fibrinogen and Associated Peptide Fragments on the Activation of Human Endothelial Cells by VEGF in Vitro

  2004cites this paper
• Comparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo

  2004cites this paper
• Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro

  2004cites this paper
• Regulation of angiogenesis by extracellular matrix.

  2004cites this paper
• Tissue factor and fibrin in tumor angiogenesis.

  2004cites this paper
• Contribution of the Hemostatic System to Angiogenesis in Cancer

  2004cites this paper
• Fibrinogen regulates the expression of inflammatory chemokines through NF-κB activation of endothelial cells

  2004cites this paper
• Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment?

  2003cites this paper
• In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.

  2003cites this paper
• Regulation of angiogenesis by the hemostatic system.

  2003cites this paper
• The role of fibrinogen and related fragments in tumour angiogenesis and metastasis

  2003cites this paper
• Tissue factor, thrombin, and cancer.

  2003cites this paper
• A von Willebrand factor-derived heparin-binding peptide regulates cell--substrate adhesive strength and chemokinesis behavior.

  2002cites this paper
• Comparative analysis of in vitro angiogenic activities of endothelial cells of heterogeneous origin.

  2002cites this paper
• Serum factors involved in human microvascular endothelial cell morphogenesis.

  2002cites this paper
• ÉCOLE DOCTORALE SCIENCES DU VIVANT, GEOSCIENCES, SCIENCES DE L'ENVIRONNEMENT

  2002cites this paper
• Roles of bradykinin in vascular permeability and angiogenesis in solid tumor.

  2002cites this paper
• Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model

  2002cites this paper
• Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors

  2001cites this paper
• Eect of Fibrinogen E-fragment on Tumour Growth

  2000cites this paper